We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Supercomputer Accelerates Pace of Health Research

By HospiMedica International staff writers
Posted on 23 Jul 2014
The University of Manchester (United Kingdom) is financing a new supercomputer system that can analyze bigger and more complex sets of information.

The Health eResearch Center (HeRC; Manchester, United Kingdom) will allow researchers from eight leading research universities access to the new Silicon Graphics International (SGI; Milpitas, CA, USA) UV2 supercomputer. More...
With an objective of using health data to improve understanding of diseases and develop better treatments and care, HeRC will merge health research and clinical practice with academic disciplines of computer science and statistics. HeRC, based in northern England, is one of four centers across the UK with partners in Scotland, Wales, and London, collectively known as The Farr Institute.

The eight universities (Durham, Lancaster, Leeds, Liverpool, Manchester, Newcastle, Sheffield, and York) collaborating together as the N8 Research Partnership already have access to a High Performance Computer (HPC) based at the University of Leeds that is capable of a peak performance of 110 trillion operations per second. Housing the new HeRC supercomputer alongside the existing facility will allow the research partnership and industry partners to speed up even further the pace of health research by allowing scientists to process data in quicker and more efficient ways.

“We are developing new ways to analyze public health information to improve our understanding of common diseases,” said John Ainsworth, MD, deputy director of HeRC. “This advanced computer system will lead to much more powerful research being conducted and enhance the speed at which researchers can produce results.”

“This is an exciting development for N8 HPC,” added Professor Chris Taylor, N8 HPC co-director. “It allows us to support a nationally important initiative in e-Health, providing a cost-effective solution by building on the existing N8 HPC infrastructure. It also extends the capability of N8 HPC for all users—a win-win.”

The SGI UV2, which runs on Intel Xeon E5 processors, doubles the number of cores (up to 4,096 cores) and quadruples the amount of coherent main memory (up to 64 terabytes) from the previous UV generation, scaling up to eight petabytes of shared memory at a peak I/O rate of four terabytes per second (14 PB/hour). For example, it could ingest the entire contents of the US Library of Congress print collection in less than three seconds.

Related Links:

Health eResearch Center
Silicon Graphics International
N8 Research Partnership



Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Hemostatic Agent
HEMOBLAST Bellows
Ureteral Dilatation Balloon
Dornier Equinox
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.